Cooperative effects of aspirin and atolvastatin on platelet function in patients undergoing coronary artery bypass grafting

• In: Hospital Pharmacy Section Posters
• At: New Orleans (USA) (2004)
• Type: Poster
• Poster code: HPS-P009
• By: NAKAMURA, Kazuo (Kagoshima University, Clinical Pharmacy and Pharmacology, Kagoshima, Japan)
• Co-author(s): Hiroko Kariyazono (Kagoshima University, KAGOSHIMA, Japan)
  Junko Arima (Kagoshima University, KAGOSHIMA, Japan)
  Shunji Onimaru (Kagoshima University, KAGOSHIMA, Japan)
  Hiroshi Masuda (Kagoshima University, KAGOSHIMA, Japan)
  Yoshifumi Iguro (Kagoshima University, KAGOSHIMA, Japan)
  Ryuzo Sakata (Kagoshima University, KAGOSHIMA, Japan)
  Katsushi Yamada (Kagoshima University, KAGOSHIMA, Japan)
  
• Abstract:

  Aspirin is one of the most effective anti-platelet drugs. Atolvastatin is a selective and competitive inhibitor of HMG-CoA reductase and is used in patients with hypercholesterolemia. In the present study, to evaluate the effects of aspirin alone (monotherapy) or the combination of aspirin with atolvastatin (combined therapy) on the function of..

The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress. Please login